PGNY Earnings Prediction
The chart below shows how PGNY performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PGNY sees a +3.95% change in stock price 10 days leading up to the earnings, and a -0.47% change 10 days following the report. On the earnings day itself, the stock moves by -0.99%. This data can give you a slight idea of what to expect for the next quarter's release.
PGNY Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
286.62M
2.04%
-5.74%
Gross Margin
20.67%
-7.27%
-7.93%
Operating Margin
4.35%
-32.87%
-36.03%
Net Margin
3.64%
-35.69%
-32.84%
EPS
0.11
-31.25%
-35.29%
No Data Available
PGNY Earnings Analysis
Progyny, Inc. Common Stock Corporation (PGNY.O) Earnings Conference Call
Positive
Quarterly Revenue Increase: Third quarter revenue grew 2% over the prior year to $286.6 million.
Client Growth Impact: The growth was primarily due to the increase in clients in covered lives as compared to a year ago.
Utilization Consistency: Third quarter utilization was 0.47%, both consistent expectations and equal to Q2's level.
Client Growth Milestone: We added 1.1 million new lives from over 80 new client commitments, marking our fourth straight year of adding over 1 million lives.
Quarterly Operating Cash Flow: Operating cash flow during the quarter was $44.5 million, which compared to $54.2 million generated in the year ago period.
Negative
Cohort Activity Disappointment: Cohort activity in Q3 continued to unfold differently from historical patterns, resulting in disappointing third quarter results that were below the ranges set in August.
Member Engagement Stagnation: The third quarter utilization rate was 0.47%, consistent with expectations but not reflective of growth, indicating a stagnation in member engagement.
Gross Profit Decline: Gross profit decreased 5% from the third quarter last year to $59.2 million, yielding a 20.7% gross margin, a 160 basis point decline from the prior year period due to investments made in care management services.
EBITDA Decline and Margin Impact: Adjusted EBITDA declined 7% to $46.5 million, and adjusted EBITDA margin decreased 160 basis points to 16.2%, reflecting the impact of lower gross margins.
Net Income Decline: Net income was $10.4 million or $0.11 per diluted share, compared to net income of $15.9 million or $0.16 per share in the year ago period, indicating a significant drop in profitability.
PGNY FAQs
How does PGNY typically perform around its earnings report dates?
Is Progyny, Inc. (PGNY) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
PGNY Earning Call Sentiment
Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
PGNY.O
-1.58%Positive
The earnings call reveals mixed signals: a slight revenue increase but decreased gross profit and net income. The share repurchase program is a positive, yet declining margins and utilization rates are concerning. The Q&A section highlighted uncertainties around utilization and gross margin drivers. While new products show promise, economic factors and competition pose risks. The company's guidance aligns with current performance, and the market cap suggests moderate volatility. Overall, these factors suggest a neutral stock price movement within -2% to 2% over the next two weeks.